11 citations
,
November 2012 in “Seminars in Cutaneous Medicine and Surgery” This review summarizes current understanding and genetic insights into androgenetic alopecia, female pattern hair loss, and alopecia areata, noting the potential future role of molecular diagnostics, but it reports no new clinical results.
10 citations
,
November 2021 in “Revista médica de Chile” This review discusses the clinical guidelines for hidradenitis suppurativa, detailing its definition, impacts, and treatments, and includes a proposed therapeutic approach algorithm, but reports no new clinical findings.
10 citations
,
January 2003 in “Seminars in reproductive medicine” This review covers the pathophysiology, diagnosis, evaluation, and treatment of hirsutism and reports no new clinical findings.
8 citations
,
April 2020 in “Facial Plastic Surgery Clinics of North America” This abstract explains that androgenetic alopecia, a common hair loss disorder influenced by genetics and hormones like dihydrotestosterone, has FDA-approved treatments including minoxidil, finasteride, and photolaser therapy, but its genetic basis and susceptibility to environmental factors remain complex.
3 citations
,
January 2014 in “International Journal of Medical Sciences” This study found that human chymase overexpression in transgenic mice may contribute to increased mortality from LPS treatment compared to wild-type mice.
2 citations
,
May 2025 in “Medicine” This source underscores the importance of understanding skin structure and function to comprehend both healthy skin biology and skin disease pathophysiology, highlighting skin's extensive involvement in healthcare due to infections, drug reactions, and diseases like psoriasis.
1 citations
,
December 2025 in “World Journal of Biology Pharmacy and Health Sciences” This review highlights that pediatric hirsutism, often linked to endocrine, metabolic, genetic, or neoplastic disorders, requires comprehensive evaluation to prevent long-term health issues, integrating advancements in androgen biosynthesis understanding and diagnostic and management strategies.
1 citations
,
January 2023 in “Journal of Clinical Medicine” This paper presents the first reported case of Acute Localized Exanthematous Pustulosis linked to topical minoxidil use, suggesting a contact-induced hypersensitivity reaction as a potential mechanism.
1 citations
,
December 2011 in “Journal of The American Academy of Dermatology” This book review examines various classification and treatment methods for acne scars, emphasizing the complexity and need for multiple therapeutic approaches, but reports no new clinical results.
1 citations
,
October 2011 in “PubMed” This review discusses the pathophysiology, diagnosis, and treatment of adolescent androgenic alopecia and reports no new clinical results.
1 citations
,
December 1997 in “PubMed” This paper reviews the pathophysiology, diagnosis, and treatment options for androgenetic alopecia, reporting no new clinical findings and highlighting potential future therapies.
June 2026 in “British Journal of Dermatology” This study examined perceptions of stress as a cause of alopecia areata among individuals in a French online cohort, finding that over half of patients considered stress a contributing factor. Additionally, patients with less understanding of their condition experienced higher levels of perceived stigma.
November 2025 in “Frontiers in Immunology” In this study, researchers found significant links between specific metabolic reprogramming-related genes and alopecia areata risk, highlighting increased SQSTM1 expression in affected hair follicles compared to healthy ones.
November 2025 in “Figshare” In this study, six metabolic reprogramming-related genes, including SQSTM1, were significantly associated with alopecia areata, with elevated SQSTM1 mRNA and protein levels observed in affected hair follicles compared to healthy controls.
September 2024 in “Brazilian Journal of Health Review” This study reviewed 16 articles to explore female pattern hair loss, highlighting its prevalence and significant impact on women's quality of life, while noting that the hormonal influences on this condition remain incompletely understood, necessitating ongoing research and therapeutic development.
August 2024 in “International Journal of Ayurveda and Pharma Research” This study provides a comprehensive review of Ayurvedic insights into Darunaka, suggesting that its management principles can still improve quality of life by addressing underlying pathophysiology.
July 2024 in “Clinical Case Reports” This study suggests that young females may experience a rare coexistence of Frontal Fibrosing Alopecia and ophiasis pattern Alopecia Areata, possibly sharing a common underlying pathophysiology.
January 2023 in “Springer eBooks” This article discusses therapeutic options for androgenetic alopecia, emphasizing the importance of aligning treatments with patient preferences, but it reports no new clinical findings.
April 2016 in “Journal of The American Academy of Dermatology” This study found that patients with androgenetic alopecia had higher symptom-related quality of life impairment than those with alopecia areata, with specific influences from age, disease duration, and severity.
April 2004 in “Journal of The American Academy of Dermatology” This review discusses the innovative features and comprehensive content of the textbook "Dermatology," highlighting its extensive illustrations, easy reference tools, and accompanying CD-ROM and website, but reports no new research findings.
October 2024 in “International Journal of Biology Pharmacy and Allied Sciences” In this research, a thorough review of hair loss issues and treatments identified the effectiveness of minoxidil and finasteride for alopecia in the scalp's vertex region, but noted concerns about their potential long-term effects, leading to increased interest in herbal therapies.
June 2023 in “International Journal of Dermatology” This study reviewed cases of congenital alopecia areata, highlighting a predominance in females and possible genetic factors, and found that topical corticosteroids were effective for hair regrowth in most treated patients, suggesting they are a suitable first-line treatment.
September 2021 in “International Journal of Biomedicine” This study found that SNPs in the MVK, ARPC1B, and CA2 genes may indicate a genetic predisposition for severe acne related to steroidogenesis.
May 1995 in “Journal of Investigative Dermatology” Researchers developed a new way to measure gene activity in single hair follicles and found that a specific gene's activity changes with different amounts and times of treatment.
November 2025 in “International Journal of Molecular Sciences” This review highlights various treatments for androgenetic alopecia that target its underlying pathophysiological mechanisms, reporting enhanced hair growth, especially when combining drugs, which shows improved outcomes over individual drug use alone.
February 2023 in “Singapore Medical Journal” Men with androgenetic alopecia have unique metabolomic patterns that could help develop targeted treatments.
December 2021 in “Intisari Sains Medis” This case report describes a 29-year-old woman with Female Pattern Hair Loss whose hair thinning reduced one month after botulinum toxin treatment.
28 citations
,
September 2014 in “Journal of Clinical Oncology” This study observed that frontal plus moderate vertex baldness at age 45 was associated with a higher risk of aggressive prostate cancer in a large cohort.
4 citations
,
February 2025 in “Acta Dermato Venereologica” People with vitiligo are more likely to also have alopecia areata.
1 citations
,
October 2023 in “Romanian Journal of Morphology and Embryology” This review analyzed 109 articles to classify skin lesions associated with COVID-19 and their frequency during the disease, but found no conclusive evidence on long-term persistence of specific types due to rarity.